Pain management pharmacology Flashcards

(38 cards)

1
Q

What are the steps of the WHO pain ladder

A

Start with non-opioids (e.g., paracetamol, NSAIDs).
Add weak opioids for mild to moderate pain (e.g., codeine, tramadol).
Introduce strong opioids for moderate to severe pain (e.g., morphine, fentanyl), possibly in combination with non-opioids.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

How do NSAID’s work and give an example of them

A

NSAIDs work by inhibiting the cyclooxygenase (COX) enzymes, which convert arachidonic acid into prostaglandins, leading to inflammation and pain. So ultimately NSAIDS inhibit prostaglandins, which inhibits the primary neuron preventing the ascending pathway. Key points include:

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the 2 kinds of COX inhibitors

A

COX 1 and COX 2 inhibitors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How does aspirin differ from other NSAIDs

A

Aspirin irreversibly inhibits COX, while other NSAIDs are reversible.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What does COX 1 do

A

COX-1 (physiological COX) occurs in most cells including gastric parietal cells where it aids in producing the stomach coating to protect the stomach from stomach acid. If it is inhibited this can cause gastric ulcer. (Why you are told to eat food with nsaids).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Explain the COX pathway

A

Membraneous phospholipids are converted to arachadonic acid to phospholipase.
COX enzymes convert arachadnic acid into prostaglandins (which cause pain and inflammation via ascending pathway)) and thromboxane.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What does COX 2 do

A

COX 2 (pathological) isn’t involved in stomach or kidney. However COX 2 does increase blood pressure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

When should selective COXibs not be given to a patient and why

A

Selective COX 2 inhibitors, reduce the minor healthy inflammation of the blood vessels which can lead to constriction of the blood vessels. This can increase blood pressure and increases risk of angina (constriction of the coronary artery) and myocardial infarction.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When should non selective NSAID’s not be given to a patient and why

A

f they are non selective they can cause issues. We need COX 1 (physiological) to produce the coating of the stomach, so if it is inhibited that protective coating is inhibited resulting in ulceration.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do NSAID’s increase the risk of Asthma attack

A

Nsaids inhibit arachidonic acid from becoming prostaglandins by inhibiting COX enzymes. This shifts the reaction and causes more Leukotriene’s to be produced by lipoxygenase which produces Cystienyl leukotrine resulting in bronchoconstriction.
If a patient has uncontrolled asthma DO NOT GIVE THEM NSAIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is paracetamols mechanism of action

A

Paracetamol is a weak inhibitor of COX-1 and COX-2, and a weak prostaglandin synthesis inhibitor, primarily acting through the descending serotonergic pathway. It is classified as an analgesic and antipyretic but is not an NSAID. Mechanism not fully understood. Can control mild but not severe pain.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is the mechanism of action of local anaesthetics and give an example of them

A

Local anaesthetics (e.g., lidocaine) are weak bases that block sodium channels, preventing action potential propagation. They can be administered topically or intrathecally and are effective in both myelinated and unmyelinated nerves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Why should local anaesthetics be administered locally or intrathecally and what may happen if it isn’t

A

They are administered locally as they block sodium channels non selectively which can lead to reducing action potentials by preventing depolarisation in cardiac cells - arryhtmia (BAD!!). They prevent pain by preventing the action potential. If they’re administered at the periphery site they prevent action potential in the primary neurone. If they’re administered at the spinal cord they can prevent action potential in the secondary neurone.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Explain the chemistry of local anaesthetics

A

They are weak bases and are partially ionised at physiological pH. Unionised forms are ester or amide so membrane permeable. In low concs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What drugs fall under the anticonvulsant class

A

Benzodiazapines Z drugs Gabapentin and pregabalin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the mechanism of action of benzodiazepines

A

Benzodiazepines always end in Zpam like diazepam and are prescribed for management of anxiety, insomnia and neuropathic pain.
Thet work by enhance GABAergic activity, providing anxiolytic and sedative effects. (mimic descending GABA pathway. Activate GABA A and B receptors and induce chloride influx and potassium efflux which reduces membrane potential which inhibits and delays AP firing and reduces NT release

17
Q

What do benzodiazepines interact with and what are the dangers associated with it

A

Benzodiazepines interact with alcohol and can cause respiratory depression and death. Also risk of addiction.

18
Q

Why would benzodiazepines be given to patients with neuropathic pain in a low or a high dose

A

Given to patients with neuropathic pain (spinal cord damage so less interneurons so less GABA released) so compensated by giving BZD’s which in low doses enhance the binding of GABA to GABA receptors and in higher doses replace GABA

19
Q

What is the mechanism of action of Z drugs

A

act like benzodiazapines but are not chemically benzodiazepines so are named Z drugs they activate GABA A and GABA B receptors which potentiate the potassium channel leading to potassium efflux and chloride influx. Reduces and delays AP firing reducing NT release

20
Q

What is the mechanism of action of gabapentinoids and pregabalin

A

By binding to alpha 2 delta VG calcium channels it prevents the influx of calcium and the movement of glutamate out of the presynaptic membrane thus preventing glutamate from binding to DRG causing euphoria relaxation and calmness

21
Q

Which 3 receptors do opioids exert effect on and what are the side effects if they are binded to and give examples of strong and weak opioids

A

Mu receptor (μ) - Main target providing analgesia
kappa receptor(κ) - spinal analgesia and hallucination
delta receptor (δ). - peripheral analgesia but proconvulsant. So opioid medicines are designed to target the mu receptor more than the others. But in high doses they will bind to the others causing side effects. Major side effects include: respiratory depression (OIRD), Arrythmia - QT interval prolongation and severe constipation

22
Q

What is the mechanism of action of opioid receptors

A

To turn this off, Mu receptors are bound to inhibitory GPCR’s. It switches off adenyl cyclase there is no ATP converter to cAMP resulting in no PKA activation and no calcium influx. At the same time there is neuronal potassium channel activation causing potassium efflux leading to reduced neurotransmission and reduced pain sensation

23
Q

What areas of the brain do opioids suppress activity in

A

Pre-Bötzinger complex in the medulla — this area is the pacemaker for breathing rhythm.

Pontine and medullary respiratory centers, which coordinate rate and depth of breathing.

These regions rely on carbon dioxide levels and other signals to trigger breaths.

24
Q

How do opioids inhibit neuronal activity and cause respiratory depression

A

Binding to μ-opioid receptors causes:

↓ cAMP

↑ K⁺ efflux (hyperpolarization)

↓ Ca²⁺ influx

Result? Decreased neuronal excitability and suppression of respiratory drive. Normally, rising CO₂ levels trigger increased breathing.

Opioids blunt the brain’s sensitivity to CO₂ → so even dangerously high CO₂ levels don’t trigger increased breathing.

The body simply doesn’t “realize” it needs more oxygen.

25
What are the risks of opioids
Loss of consciousness Respiratory arrest Death Risk is higher when: Combined with alcohol, benzodiazepines, or other CNS depressants. In people with sleep apnea or lung disease. In opioid-naïve patients or after relapse following tolerance loss.
26
27
What reverses opioids action
Naloxone is a μ-opioid receptor antagonist. It kicks the opioid off the receptor → rapidly restores respiratory drive. However, its effect is short-lived, especially with long-acting opioids — repeated doses or monitoring may be necessary.
28
What is the mechanism of action of NMDA receptor blockers and give an example of one
NMDA receptor antagonists, such as ketamine, provide analgesia by blocking excitatory neurotransmission. They are used for acute pain relief and given intrathecally to prevent memory and cognitive impairment.
29
What is the mechanism of action of antidepressants and give an example of one
Tricyclic antidepressants (TCAs) and SNRIs enhance the availability of serotonin and norepinephrine (Increase serotonin and noradrenaline), improving pain management. TCAs (Imipramine and amitriptyline) do this by inhibiting reuptake of serotonin and NA which enhances the descending pathways secondary neurones effects. TCA’s have more side effects compared to SNRIs (because they’re more potent) such as cardiovascular and anticholinergic (anti Ach effects) side effects) SNRI’s (venlafaxine and duloxetine) (selective serotonin and noradrenaline reuptake inhibitors do the same thing with less side effects - used for trigeminal (CNV) neuralgia. May cause sexual impotence
30
What types of drugs fall under migraine drugs
Triptans, Anti-CGRP receptor blockers, Monoclonal antibodies Propranalol (beta adrenergic receptor antagonist) Botulinium toxin A. TRPV1 Agonists
31
What is the mechanism of action of triptans
triptans, which activate 5-HT1 receptors to induce vasoconstriction and inhibit CGRP release. If VIP & PACAP bind to the receptor it leads to cerebral vasodilation and migraine. When triptans bind to 5-HT1D receptor (serotonin receptor), this induces cerebral vasoconstriction reducing the pain of the migraine
32
What is the mechanism of action of Anti-CGRP receptor blockers and monoclonal antibodies
Anti-CGRP receptor blockers and monoclonal antibodies are also used for prevention. Neurone releases CGRP which binds to CGRP receptor and induces cerebral vasodilation. If the receptor is blocked this can help prevent migraines. Antibodies target the CGRP itself
33
What is the mechanism of action of propranolol and what are the risks
Beta adrenergic receptors are located on cerebral blood vessels mediate vasodilation. Propranolol is a first line preventative treatment in patients with episodic or chronic migraine. Risk of using propranolol because it is a beta blocker and the heart tissue has beta-1 receptors so it can lead to reduced heart rate (bradychardia). The lungs and bronchi also have beta receptors. So if these are blocked they can cause bronchoconstriction (DO NOT GIVE TO ASTHMATICS!!!).
34
What is the mechanism of action of botulinum toxin A
CGRP is released from the neurone to the intracranial arteries from the trigeminal nerve. It’s release is dependant on its vesicle fusing with the neuronal membrane. This happens through the formation of a SNAP-SNAREceptor complex Vesicle associated membrane proteins VAMP’S bind to SNAP25 complexes to release the neurotransmitter. Botulinum toxin A cleaves snap 25 preventing this
35
What is the mechanism of action of TRPV1 agonists why does it induce inflammation first
Capsaicin, a TRPV1 agonist, is used topically for localized neuropathic pain (postherpic/diabetes). It desensitizes TRPV1 receptors, leading to reduced pain sensation. In the pain pathway diagram TRPV1R is activated by TRPV1 at the start of the pathway which causes the release of SP and CGRP causing histamine release from mast cells and vasodilation. This continuous triggering of TRPV1R depletes the amount of TRPV1 agonist and SP. It induces inflammation at first but renders skin insensitive to pain.
36
What is the mechanism of action of general anaesthetics
General anaesthesia involves multiple stages, from induction to surgical anaesthesia. Most anaesthetics enhance GABA activity, while some inhibit NMDA receptors. Common agents include propofol and nitrous oxide. Not entirely understood no one mechanism.
37
What are the four stages of of using general anaesthetics
*Stage 1: induction stage (Analgesia or Disorientation): The patient is given medication and may begin to feel its effects but has not yet become unconscious. Patients are sedated but conversational. Breathing is slow and regular. This stage comes to an end with the loss of consciousness. *Stage 2: Excitement or Delirium: This stage is marked by features such as disinhibition, delirium, uncontrolled movements, loss of eyelash reflex, hypertension, and tachycardia. Airway reflexes remain intact during this phase and are often hypersensitive to stimulation. There is a higher risk of laryngospasm (involuntary tonic closure of vocal cords) at this stage, which may be aggravated by any airway manipulation. Fast-acting agents help reduce the time spent in stage 2 as much as possible and facilitate entry to stage 3. *Stage 3: Surgical Anesthesia: This is the targeted anesthetic level for procedures requiring general anesthesia. Ceased eye movements and respiratory depression are the hallmarks of this stage. *Stage 4: Overdose: This stage occurs when too much anesthetic agent is given relative to the amount of surgical stimulation, which results in worsening of an already severe brain or medullary depression. This stage begins with respiratory cessation and ends with potential death üPatients should go from stage 1 to stage 3 smoothly and maintained at stage 3
38
What non pharmacological approaches are there
Transcutaneous electrical nerve stimulation (TENS) may provide pain relief through various mechanisms, including activation of descending pain inhibitory pathways. However, evidence for its efficacy is limited.